Summary & Overview
CPT 81415: Exome Sequence Analysis for Unexplained Heritable Disorders
CPT code 81415 represents exome sequence analysis, a comprehensive genetic testing procedure used to investigate unexplained constitutional or heritable disorders and syndromes. This code is nationally significant as exome sequencing has become a cornerstone in the diagnosis of rare and complex genetic conditions, enabling clinicians to pinpoint underlying causes that may not be detectable through standard testing methods. The procedure is typically performed in laboratory settings and is increasingly utilized in both pediatric and adult populations.
Major payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare. The publication provides an overview of payer coverage policies, clinical indications, and relevant coding practices for 81415. Readers will gain insights into current benchmarks for utilization, policy updates affecting reimbursement, and the clinical context in which exome sequencing is ordered. The summary also highlights associated modifiers, taxonomies, and related CPT codes, offering a comprehensive view of how this procedure fits into broader genetic testing workflows.
This article is designed for healthcare professionals, billing specialists, and policy analysts seeking up-to-date information on exome sequence analysis, its clinical applications, and payer landscape. The content is organized to deliver key facts first, followed by supporting details and context.
CPT Code Overview
CPT code 81415 is used for exome sequence analysis, a form of genetic testing that helps identify unexplained constitutional or heritable disorders and syndromes. This procedure is typically performed in a laboratory setting (Place of Service 81) and is a critical tool in the diagnosis and management of complex genetic conditions. Exome sequencing analyzes the protein-coding regions of the genome, providing valuable insights for clinicians and patients facing unexplained medical presentations. The service type is genetic testing, which plays a pivotal role in modern precision medicine and personalized healthcare.
Clinical & Coding Specifications
Clinical Context
A patient, often a child or young adult, presents with unexplained developmental delays, congenital anomalies, or features suggestive of a heritable disorder. Despite prior genetic testing, the underlying cause remains unclear. The clinician, typically a medical geneticist, orders exome sequencing (CPT 81415) to analyze the coding regions of the patient's genome for pathogenic variants. The specimen is sent to a specialized laboratory (Place of Service 81), where the sequencing and interpretation are performed. Results may guide diagnosis, management, and genetic counseling for the patient and family.
Coding Specifications
-
Modifier
26: Used when only the professional component (interpretation and report) of the exome sequencing is performed by the provider, not the technical laboratory work. -
Modifier
59: Indicates a distinct procedural service, used when exome sequencing is performed separately from other procedures or tests.
| Modifier Code | Description |
|---|---|
26 |